NCT05390658

Brief Summary

ECMO has been used to save the lives of many critically ill patients with cardiorespiratory dysfunction as important rescue therapy. Though the proportion of ECMO applied to this population has been increasing year by year, clinical outcomes of AMI remain poor with high in-hospital mortality. Thus, it is necessary to characterize clinical features and investigate potentially modifiable factors contributing to outcomes of AMI patients who received ECMO treatment.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
80

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2020

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 11, 2020

Completed
2.3 years until next milestone

First Submitted

Initial submission to the registry

May 16, 2022

Completed
9 days until next milestone

First Posted

Study publicly available on registry

May 25, 2022

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 12, 2022

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 12, 2023

Completed
Last Updated

May 25, 2022

Status Verified

May 1, 2022

Enrollment Period

2.8 years

First QC Date

May 16, 2022

Last Update Submit

May 19, 2022

Conditions

AMI - Acute Mesenteric IschemiaExtracorporeal Membrane Oxygenation Complication

Outcome Measures

Primary Outcomes (1)

  • Survival rate

    Survival information from ICU entry to ICU exit

    1 month

Study Arms (2)

Survival

Other: Not application

Death

Other: Not application

Interventions

Not applicationOTHER

Not application

DeathSurvival

Eligibility Criteria

Age18 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

I. Clinical symptoms: the typical angina pectoris symptoms of acute myocardial infarction are compressive pain in the precardiac area and the back of the sternum, accompanied by sweating, a sense of dying, and a sense of suffocation. Taking nitroglycerin tablets or quick-effect Xusuxin pills cannot alleviate the symptoms. 2\. Typical ECG manifestations, such as pathological Q wave, ST-segment elevation, or pathological ST-segment depression, have corresponding lead changes. 3\. Increased myocardial enzymes, including CK, CK-MB, and troponin, etc. The diagnosis of acute myocardial infarction can be made with two of these three indicators.

You may qualify if:

  • Clinical diagnosis of Alzheimer's Disease Age more than 18

You may not qualify if:

  • Life expectancy \<1 year Prolonged cardiac arrest before VA-ECMO therapy (\>60 min) Iatrogenic myocardial infarction secondary to a percutaneous coronary intervention VA-ECMO implanted in another center before admission

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Genglong Liu

Guangzhou, State..., 510080, China

RECRUITING

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
OTHER
Target Duration
2 Months
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Clinical Professor

Study Record Dates

First Submitted

May 16, 2022

First Posted

May 25, 2022

Study Start

January 11, 2020

Primary Completion

November 12, 2022

Study Completion

January 12, 2023

Last Updated

May 25, 2022

Record last verified: 2022-05

Locations

CN(1)